Inventaire - your friends and communities are your best library

Levodopa-induced dyskinesias and their management.

author

Alberto Albanese

1953 -

published in: Journal of Neurology

date of publication: 2008-08-01

main subject: dyskinesia, levodopa

Cites articles 83

Date

Title

Authors

2008-04-01

PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum.

Daniele Ghezzi, Bruno Dallapiccola, Anna Rita Bentivoglio, Emanuele Cassetta, Barbara Garavaglia, Enza Maria Valente, Alberto Albanese, Michele Tinazzi, Angelo Antonini, Paolo Barone, Gianni Pezzoli, Maria Teresa Pellecchia, Massimo Zeviani, Roberta Marongiu, Francesco Soleti, Maria Concetta Altavista, Livia Brusa, Cesa Scaglione, Paolo Stanzione
2008-02-12

Parkinson's disease: levodopa-induced dyskinesia and signal transduction

Emmanuel Valjent
2007-01-01

Pathophysiology of motor complications in Parkinson disease: postsynaptic mechanisms are crucial
2007-07-01

Levodopa-induced dyskinesias

Christopher G. Goetz, Giovanni Fabbrini, Jonathan M. Brotchie
2007-08-16

Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias

Thérèse Di Paolo
2007-06-01

Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.

Angelo Antonini, Ioannis Isaias, Maurizio Zibetti, Gianni Pezzoli, Leonardo Lopiano
2007-01-01

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial

Eugene Laska, Olivier Rascol, Christopher G. Goetz, Charles Warren Olanow, Thomas Müller
2007-07-01

Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life.

Galit Kleiner-Fisman, Matthew B. Stern
2006-06-01

STN DBS in PD: selection criteria for surgery should include cognitive and psychiatric factors.
2006-11-01

Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

David J. Brooks, Amos D. Korczyn, Carl E Clarke, Anthony Lang
2006-10-01

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure

Anthony Lang, Susan H Fox, Jonathan M. Brotchie
2006-04-01

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Janis M. Miyasaki, Kelly Lyons, Rajesh Pahwa
2006-04-01

Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism

Anette Schrag
2005-01-01

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
2005-12-01

Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study

Carl E Clarke
2005-05

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

Werner Poewe, Cristina Sampaio, Olivier Rascol, Christopher G. Goetz
2005-04-01

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.

Antonio Gambardella, Aldo Quattrone, Grazia Annesi, Patrizia Tarantino, Sara Carrideo, Mario Zappia
2005-02-01

Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.

Andrew John Lees, Regina Katzenschlager, Kailash Phatechand Bhatia, Niall P Quinn, Marion Hoffman, Andrew J. Hughes, Andrew H Evans
2005-03-01

Levodopa-dyskinesia incidence by age of Parkinson's disease onset

J Eric Ahlskog
2005-02-01

Impact of the motor complications of Parkinson's disease on the quality of life
2005-06-01

The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease.

Luigi M. Romito, Bruno Dallapiccola, Alberto Albanese
2005-08-01

Nondopaminergic mechanisms in levodopa-induced dyskinesia

Jonathan M. Brotchie
2004-01-01

Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations

Murray Krahn, George Tomlinson, Anthony Lang, Connie Fernández-Cid Marras, Parkinson Study Group, Gary Naglie
2004-07-01

Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms

Frédéric Calon, Thérèse Di Paolo, Abdallah Hadj Tahar, Richard Grondin, Leonard T Meltzer
2004-01-01

Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease
2003-06-01

L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
2003-12-01

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

Frédéric Calon, Thérèse Di Paolo, Oleh Hornykiewicz
2003-05-01

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets
2003-08-22

[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease

Vesna Sossi
2003-06-01

Parkin disease: a phenotypic study of a large case series

Nicholas W. Wood, Andrew John Lees, Kailash Phatechand Bhatia, Niall P Quinn
2003-11-01

Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences.

Anette Schrag, Niall P Quinn
2002-06-01

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase

Article - wd:Q37280804

Welcome to Inventaire

the library of your friends and communities

learn more